Postdoctoral researcher
Dr. XU Wenye
PhD
Postdoctoral Fellow
Department of Anaesthesia and Intensive Care
The Chinese University of Hong Kong
My current research interests are in Gut microbiota
Publications:
For details about citations arising from my publications and links to online versions of some of the publications, refer to: https://orcid.org/0009-0002-4646-4823
(*corresponding author, ^co-first author)
- Xu W*, Su P*, et al; In vivo Imaging of a Novel Strain of Bacteroides fragilis via Metabolic Labeling. Front Microbiol. 2018 Oct 1;9:2298.[IF2022 =5.2]
- Fang S*, Zhang L*, Liu Y*, Xu W*, et al; Lysosome activation in peripheral blood mononuclear cells and prognostic significance of circulating LC3B in COVID-19. Brief Bioinform. 2021 Mar 22;22(2):1466-1475. [IF2022= 9.5]
- Zhang L, Zhan H, Xu W, Yan S, et al; The role of gut mycobiome in health and diseases. Therap Adv Gastroenterol. 2021 Sep 23;14:17562848211047130. [IF2022= 4.2]
- Xu W*, Liu Y*, Zou X*, Luo H*, Wu W*, et al; Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response. Front Immunol. 2022 Jan 4;12:785599. [IF2022= 7.3]
- Sun X, Liu Y, Huang Z, Xu W, et al; SARS-CoV-2 non-structural protein 6 triggers NLRP3- dependent pyroptosis by targeting ATP6AP1. Cell Death Differ. 2022 Jun;29(6):1240-1254. doi: 10.1038/s41418-021-00916-7. Epub 2022 Jan 8. [IF2022=12.4]
- Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, Zhan H, Lu W, Xu W, et al; Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology. 2022 Feb;162(2):548-561.e4. [IF2022= 29.4]